---
title: "Pebblebrook Hotel Trust Stock 12‑Month Price Target Cut to $18.3, Implies 1% Downside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295279788.md"
description: "Pebblebrook Hotel Trust's average 12-month price target was lowered to $18.3 from $18.52 by 14 analysts, implying a 1% downside based on the Aug. 6 close. The consensus rating remains 'Hold' among 16 covering analysts, comprising 4 Buys, 9 Holds, and 3 Sells."
datetime: "2026-08-07T21:20:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295279788.md)
  - [en](https://longbridge.com/en/news/295279788.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295279788.md)
---

# Pebblebrook Hotel Trust Stock 12‑Month Price Target Cut to $18.3, Implies 1% Downside

-   According to estimates from 14 analysts, Pebblebrook Hotel Trust stock's average price target has fallen from $18.52 to $18.3, with forecasts ranging from $13 to $22 per share
-   Based on the Aug. 6 closing price, the updated target implies approximately 1% potential downside
-   Consensus rating remains at “Hold” across 16 covering analysts, with 4 Buys, 9 Holds and 3 Sells

Explore more price target data and ratings for Pebblebrook Hotel Trust on the , and track all previous and future analyst recommendations for Pebblebrook Hotel Trust in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [PEB.US](https://longbridge.com/en/quote/PEB.US.md)

## Related News & Research

- [Pebblebrook Hotel Trust (NYSE:PEB) Posts Earnings Results, Beats Estimates By $0.05 EPS](https://longbridge.com/en/news/294258763.md)
- [Pebblebrook Hotel Trust $PEB Stock Holdings Lifted by Arrowstreet Capital Limited Partnership](https://longbridge.com/en/news/294318699.md)
- [Toro 18 Holdings reports $349,739 UEI common share disposal](https://longbridge.com/en/news/296412290.md)
- [Should White Mountains (WTM) Investors React to Strong Q2 Earnings and a Major Share Buyback?](https://longbridge.com/en/news/296004368.md)
- [Should FDA Clearance Of QIAstat-Dx Sepsis Panel Require Action From Qiagen (QGEN) Investors?](https://longbridge.com/en/news/296027748.md)